Penobscot Investment Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.17M | Sell |
26,577
-1,709
| -6% | -$256K | 0.29% | 82 |
|
|
2026
Q1 | $4.32M | Sell |
28,286
-30
| -0.1% | -$4.6K | 0.34% | 71 |
|
|
2025
Q4 | $3.9M | Sell |
28,316
-1
| -0% | -$131 | 0.29% | 77 |
|
|
2025
Q3 | $3.63M | Buy |
28,317
+2,550
| +10% | +$311K | 0.28% | 78 |
|
|
2025
Q2 | $3.12M | Hold |
25,767
| – | – | 0.27% | 81 |
|
|
2025
Q1 | $2.87M | Buy |
25,767
+1,550
| +6% | +$165K | 0.27% | 82 |
|
|
2024
Q4 | $2.36M | Sell |
24,217
-750
| -3% | -$80K | 0.21% | 97 |
|
|
2024
Q3 | $2.87M | Buy |
24,967
+200
| +0.8% | +$22.7K | 0.26% | 83 |
|
|
2024
Q2 | $2.64M | Buy |
24,767
+6,265
| +34% | +$629K | 0.25% | 79 |
|
|
2024
Q1 | $1.79M | Buy |
18,502
+445
| +2% | +$45.6K | 0.19% | 109 |
|
|
2023
Q4 | $1.82M | Buy |
18,057
+3,489
| +24% | +$337K | 0.21% | 97 |
|
|
2023
Q3 | $1.48M | Buy |
14,568
+10,943
| +302% | +$1.11M | 0.2% | 107 |
|
|
2023
Q2 | $366K | Sell |
3,625
-450
| -11% | -$45K | 0.06% | 171 |
|
|
2023
Q1 | $375K | Hold |
4,075
| – | – | 0.07% | 169 |
|
|
2022
Q4 | $370K | Hold |
4,075
| – | – | 0.06% | 172 |
|
|
2022
Q3 | $310K | Hold |
4,075
| – | – | 0.06% | 180 |
|
|
2022
Q2 | $345K | Hold |
4,075
| – | – | 0.06% | 176 |
|
|
2022
Q1 | $358K | Hold |
4,075
| – | – | 0.05% | 188 |
|
|
2021
Q4 | $356K | Sell |
4,075
-100
| -2% | -$8.3K | 0.05% | 196 |
|
|
2021
Q3 | $342K | Sell |
4,175
-895
| -18% | -$80.5K | 0.05% | 194 |
|
|
2021
Q2 | $463K | Sell |
5,070
-2,750
| -35% | -$245K | 0.07% | 164 |
|
|
2021
Q1 | $668K | Sell |
7,820
-675
| -8% | -$60.6K | 0.11% | 142 |
|
|
2020
Q4 | $802K | Sell |
8,495
-600
| -7% | -$52.4K | 0.13% | 127 |
|
|
2020
Q3 | $790K | Sell |
9,095
-880
| -9% | -$76.2K | 0.15% | 124 |
|
|
2020
Q2 | $871K | Sell |
9,975
-150
| -1% | -$12.9K | 0.18% | 107 |
|
|
2020
Q1 | $835K | Sell |
10,125
-86
| -0.8% | -$7.67K | 0.2% | 105 |
|
|
2019
Q4 | $967K | Sell |
10,211
-330
| -3% | -$29.6K | 0.18% | 111 |
|
|
2019
Q3 | $916K | Sell |
10,541
-270
| -2% | -$24.2K | 0.18% | 112 |
|
|
2019
Q2 | $988K | Sell |
10,811
-1,366
| -11% | -$116K | 0.2% | 104 |
|
|
2019
Q1 | $1.05M | Sell |
12,177
-502
| -4% | -$40.3K | 0.22% | 99 |
|
|
2018
Q4 | $974K | Sell |
12,679
-770
| -6% | -$59.9K | 0.23% | 98 |
|
|
2018
Q3 | $1.04M | Sell |
13,449
-530
| -4% | -$39.2K | 0.22% | 103 |
|
|
2018
Q2 | $946K | Sell |
13,979
-2,979
| -18% | -$206K | 0.22% | 104 |
|
|
2018
Q1 | $1.23M | Buy |
16,958
+12,465
| +277% | +$949K | 0.29% | 88 |
|
|
2017
Q4 | $338K | Hold |
4,493
| – | – | 0.09% | 150 |
|
|
2017
Q3 | $346K | Hold |
4,493
| – | – | 0.1% | 149 |
|
|
2017
Q2 | $336K | Sell |
4,493
-391
| -8% | -$27.7K | 0.11% | 149 |
|
|
2017
Q1 | $325K | Sell |
4,884
-491
| -9% | -$32.7K | 0.11% | 146 |
|
|
2016
Q4 | $351K | Sell |
5,375
-178
| -3% | -$11.5K | 0.12% | 135 |
|
|
2016
Q3 | $393K | Sell |
5,553
-882
| -14% | -$64.3K | 0.14% | 131 |
|
|
2016
Q2 | $476K | Sell |
6,435
-8,962
| -58% | -$619K | 0.17% | 115 |
|
|
2016
Q1 | $999K | Sell |
15,397
-5,277
| -26% | -$359K | 0.37% | 79 |
|
|
2015
Q4 | $1.59M | Buy |
20,674
+2,009
| +11% | +$160K | 0.5% | 65 |
|
|
2015
Q3 | $1.54M | Buy |
18,665
+3,379
| +22% | +$301K | 0.52% | 63 |
|
|
2015
Q2 | $1.35M | Buy |
15,286
+915
| +6% | +$83.9K | 0.42% | 70 |
|
|
2015
Q1 | $1.27M | Hold |
14,371
| – | – | 0.4% | 76 |
|
|
2014
Q4 | $1.19M | Hold |
14,371
| – | – | 0.38% | 78 |
|
|
2014
Q3 | $1.21M | Sell |
14,371
-524
| -4% | -$42.4K | 0.4% | 74 |
|
|
2014
Q2 | $1.21M | Buy |
14,895
+54
| +0.4% | +$4.25K | 0.41% | 72 |
|
|
2014
Q1 | $1.13M | Buy |
14,841
+335
| +2% | +$24.4K | 0.4% | 71 |
|
|
2013
Q4 | $1.04M | Sell |
14,506
-44
| -0.3% | -$3.06K | 0.37% | 75 |
|
|
2013
Q3 | $1M | Sell |
14,550
-406
| -3% | -$26.9K | 0.39% | 71 |
|
|
2013
Q2 | $947K | Buy |
+14,956
| New | +$973K | 0.39% | 69 |
|
Other funds holding NVS
Penobscot Investment Management's NVS Position: Q2 2026 in Review
Penobscot Investment Management reduced its Novartis (NVS) stake by 6% in Q2 2026, selling an estimated $256K and leaving 26,577 shares worth $4.17M. The position accounts for 0.29% of the portfolio, ranked #82.
Penobscot Investment Management first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.32M in Q1 2026. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Penobscot Investment Management held 26,577 shares of Novartis worth $4.17M as of Q2 2026.
- Penobscot Investment Management sold 1,709 Novartis shares in Q2 2026, an estimated $256K.
- Novartis made up 0.29% of Penobscot Investment Management's portfolio in Q2 2026, its #82 holding.
- Penobscot Investment Management first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Penobscot Investment Management's Novartis position peaked at $4.32M in Q1 2026.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.